Dr. Reddy’s Laboratories has launched its ziprasidone mesylate 20 mg/mL for injection, the first generic version of Geodon (Pfizer) for injection.
Alkermes is seeking FDA approval for its investigational antipsychotic drug candidate ALKS 3831 for schizophrenia and bipolar I disorder.
Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study.
Albertsons is expanding its partnership with Genomind to offer patients genetic testing to guide mental health medication management.
New services will start with select pharmacists before expanding to Walgreens team memebers and potentially a nationwide resource.